摘要
目的:研究大肠癌患者p5 3基因突变及蛋白表达之间关系,并探讨从粪便中检测p5 3基因突变在大肠癌早期诊断中的临床意义。方法:采用聚合酶链反应单链构象多态性分析(PCR SSCP)法,检测大肠癌患者癌组织和粪便标本中p5 3基因第5~8外显子突变情况;同时运用免疫组化法分析癌组织中p5 3表达情况。结果:34例大肠癌患者癌组织标本中,p5 3基因第5~8外显子突变及蛋白表达阳性率分别为5 2 .9%和5 5 .9% ,正常黏膜未见p5 3表达(P <0 .0 1)。p5 3表达与基因突变呈正相关关系(P <0 .0 5 )。p5 3表达阳性率与肿瘤组织大小有关,肿瘤≤5cm者阳性率高于>5cm者(P <0 .0 5 ) ,但与其它临床病理因素无关。12例癌组织中有p5 3基因突变的患者其粪便中基因突变阳性率为4 1.7% ,正常人未检测出突变。结论:p5 3基因突变是参与和影响p5 3表达和生物学功能的主要因素;大肠癌患者粪便中可检测出p5 3基因突变,粪便中p5
Objective:To study the relationship between p53 gene mutation and the protein expression,and their roles in the early diagnosis and clinical significances in colorectal cancer.Methods:Using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP),the mutations in exon 58 of p53 gene were examined in the tumor tissues and stool of 34 patients and 10 healthy controls.At the same time,using immunohistochemistry(IHC)(S-Pmethods),p53 protein expression were examined in the tumor tissues and normal mucosa.Results:The mutation of exon 58 and protein expression of p53 gene in the tissues were found in 18 of 34(52.9%) cases and 19 of 34(55.9%) cases,respectively,no mutation and protein expression were positive in normal mucosa(P<(0.01)).Of 12 patients who were positive for p53 gene mutation in tumor tissue,5(41.7%) had evidence of alterations in the p53 gene within the stool.The positive rates of p53 protein expression was correlates with the mutation of exon 58.The expression of p53 protein was correlated with tumor size(P<0.05),but not correlates to other cliniopathological factors.Conclusions:Our data indicate that gene mutation of p53 is one of the main factors which participate and affect the protein expression.p53 gene mutation can be detected within the stools.Detection of p53 gene in stool may provide new ways for the early diagnosis and census of high risk population in colorectal cancers.
出处
《蚌埠医学院学报》
CAS
2005年第3期195-197,共3页
Journal of Bengbu Medical College
基金
安徽省教育厅自然科学研究资助项目 (2 0 0 0jL12 3 )
关键词
大肠肿瘤
基因
P53
聚合酶链反应
免疫组织化学
colorectal neoplasms
genes
p53
polymerase chain reaction
immunohistochemistry